Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Belimumab for Maintenance Therapy in Idiopathic Inflammatory Myositis

NCT02347891 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT02347891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02347891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Belimumab for Maintenance Therapy in Idiopathic Inflammatory Myositis
Lead sponsor
Northwell Health
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2015
Completion date
November 30, 2020
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myositis